相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
Ibrahim E. Awad et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
Sukanth Kumar Enmozhi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
K. G. Arun et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Methotrexate inhibits SARS-CoV-2 virus replication in vitro
Arnaldo Caruso et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Be well: A potential role for vitamin B in COVID-19
Hira Shakoor et al.
MATURITAS (2021)
Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2
Chao Liu et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2021)
Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies
Atala B. Jena et al.
SCIENTIFIC REPORTS (2021)
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
Sinead M. O'Donovan et al.
SCIENTIFIC REPORTS (2021)
Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses
Guobing Li et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
Yan-Chao Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases
Deyin Guo
VIROLOGICA SINICA (2020)
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Home Nitric Oxide Therapy for COVID-19
Roger A. Alvarez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
Solomon Habtemariam et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics
Arun K. Ghosh et al.
CHEMMEDCHEM (2020)
Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity
Yongkang Chen et al.
FRONTIERS IN MICROBIOLOGY (2020)
COVID-19 Drug Discovery Using Intensive Approaches
Ayumu Asai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
Aleix Gimeno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Junmei Wang
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Yan Gao et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
Donald C. Hall et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC'1 attack
Elliot M. Frohman et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Baricitinib for COVID-19: a suitable treatment?
Ennio G. Favalli et al.
LANCET INFECTIOUS DISEASES (2020)
SARS-CoV-2: virus dynamics and host response
Yu Chen et al.
LANCET INFECTIOUS DISEASES (2020)
Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease
Motonori Tsuji
FEBS OPEN BIO (2020)
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Sisi Kang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
Umesh Kalathiya et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins
Tommy Tsan-Yuk Lam et al.
NATURE (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection
Chhanda Charan Danta
ACS CHEMICAL NEUROSCIENCE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Yuzhi Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
Shiyong Fan et al.
FUTURE MEDICINAL CHEMISTRY (2020)
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
Carlo Perricone et al.
IMMUNOLOGIC RESEARCH (2020)
Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
Marvin Edeas et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
COVID-19: Drug Targets and Potential Treatments
Carmen Gil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Angela Patri et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
Tamer N. Jarada et al.
JOURNAL OF CHEMINFORMATICS (2020)
Drug repurposing approach to fight COVID-19
Thakur Uttam Singh et al.
PHARMACOLOGICAL REPORTS (2020)
Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach
Shuvasish Choudhury et al.
Medical Journal Armed Forces India (2020)
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Mohammad M. Ghahremanpour et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Mathieu Gendrot et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence
Jean Barre et al.
FRONTIERS IN PHARMACOLOGY (2020)
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
Jie Fang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19
Xueting Li et al.
ACTA PHARMACEUTICA SINICA B (2020)
Union is strength: antiviral and anti-inflammatory drugs for COVID-19
Jose J. Naveja et al.
DRUG DISCOVERY TODAY (2020)
COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies
Semih Baghaki et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 A Randomized Clinical Trial
Wesley H. Self et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity
Sunil Raghav et al.
FRONTIERS IN MICROBIOLOGY (2020)
Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19
Giovanni Bocci et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)
Simona De Vita et al.
RSC ADVANCES (2020)
COVID-19: A review of the proposed pharmacological treatments
Sarah Lam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Genomic characterization of a novel SARS-CoV-2
Rozhgar A. Khailany et al.
GENE REPORTS (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Computational Drug Repurposing: Current Trends
Berin Karaman et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
Xin Chen et al.
MEDICAL SCIENCE MONITOR (2019)
An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice
Ludek Eyer et al.
JOURNAL OF VIROLOGY (2019)
Mechanism of Action of Methotrexate Against Zika Virus
Sungjun Beck et al.
VIRUSES-BASEL (2019)
HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity
Shiying Wu et al.
NATURE CELL BIOLOGY (2019)
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy
Thomas G. Cotter et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids
Hiroaki Kume et al.
FRONTIERS IN PHARMACOLOGY (2019)
Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation: A Meta-Analysis
Mohammad Esmadi et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2019)
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Min-Han Lin et al.
ANTIVIRAL RESEARCH (2018)
Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein
Febrina Meutiawati et al.
ANTIVIRAL RESEARCH (2018)
Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists
Dong Yan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
Wenfei Song et al.
PLOS PATHOGENS (2018)
Ezetimibe inhibits dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann-Pick C1-like 1 receptor
Juan Fidel Osuna-Ramos et al.
ANTIVIRAL RESEARCH (2018)
Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease
Raed Daher et al.
PRESSE MEDICALE (2017)
Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
Xufang Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations
Kevin W. Graepel et al.
MBIO (2017)
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
Paula M. Perin et al.
HEPATOLOGY (2016)
Evaluation of the anti-inflammatory effects of β-adrenoceptor agonists on human lung macrophages
Sharonjit K. Gill et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs
Alexander Karlas et al.
NATURE COMMUNICATIONS (2016)
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
Julia Marschallinger et al.
NATURE COMMUNICATIONS (2015)
Identification and Further Development of Potent TBK1 Inhibitors
Andre Richters et al.
ACS CHEMICAL BIOLOGY (2015)
Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
Douglas B. Kell et al.
METALLOMICS (2014)
Transport Rankings of Non-Steroidal Antiinflammatory Drugs across Blood-Brain Barrier In Vitro Models
Iveta Novakova et al.
PLOS ONE (2014)
SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex
Xiaojuan Chen et al.
PROTEIN & CELL (2014)
Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease: From Clinical Trials to Daily Practice
Cristoforo Incorvaia et al.
REVIEWS ON RECENT CLINICAL TRIALS (2014)
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
Julie Lucifora et al.
ANTIVIRAL RESEARCH (2013)
Synergistic Inhibitor Binding to the Papain-Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications
Hyun Lee et al.
CHEMMEDCHEM (2013)
Macimorelin (AEZS-130)-Stimulated Growth Hormone (GH) Test: Validation of a Novel Oral Stimulation Test for the Diagnosis of Adult GH Deficiency
J. M. Garcia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Xuan-Yu Meng et al.
Current Computer-Aided Drug Design (2012)
Integrating Ligand-Based and Protein-Centric Virtual Screening of Kinase Inhibitors Using Ensembles of Multiple Protein Kinase Genes and Conformations
Anshuman Dixit et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase
Adeyemi O. Adedeji et al.
PLOS ONE (2012)
Nebivolol: impact on cardiac and endothelial function and clinical utility
Jorge Eduardo Toblli et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2012)
A structural analysis of M protein in coronavirus assembly and morphology
Benjamin W. Neuman et al.
JOURNAL OF STRUCTURAL BIOLOGY (2011)
Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 Complex
Etienne Decroly et al.
PLOS PATHOGENS (2011)
Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2010)
The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells
Anne-Marie Scola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2
Jason Netland et al.
JOURNAL OF VIROLOGY (2008)
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
Robert Eferl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection
Matthijs Raaben et al.
VIROLOGY JOURNAL (2007)
New method for fast and accurate binding-site identification and analysis
Tom Halgren
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
RNA recognition and cleavage by the SARS coronavirus endoribonuclease
Kanchan Bhardwaj et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesis
E Minskaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Antibody detection of SARS-CoV spike and nucleocapsid protein
MS Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus
RT He et al.
VIRUS RESEARCH (2004)
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers
FG Hayden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Tools for comparative protein structure modeling and analysis
N Eswar et al.
NUCLEIC ACIDS RESEARCH (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
分享论文
